Vaccine Therapy in Treating Patients at High Risk for Breast Cancer Recurrence

Completed · Not applicable

Conditions studied: Breast Cancer

In brief

RATIONALE: Vaccines may make the body build an immune response and decrease the recurrence of breast cancer. PURPOSE: Pilot trial to study the effectiveness of vaccine therapy in treating patients who are at high risk for breast cancer recurrence.

Key facts

Study ID

NCT00030823

Run by

Memorial Sloan Kettering Cancer Center

People needed

14

Starts

2001-03-01

Expected to finish

2009-02-01

Last updated by the study team

2015-12-30

Who can join

Age: 18 and older, up to 120. Sex: any. Healthy volunteers: not accepted.

Where it is running

• Memorial Sloan-Kettering Cancer Center — New York, New York, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.